Sec Form 4 Filing - AYERS JONATHAN W @ IDEXX LABORATORIES INC /DE - 2014-01-31

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
AYERS JONATHAN W
2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chairman, President & CEO
(Last) (First) (Middle)
ONE IDEXX DRIVE
3. Date of Earliest Transaction (MM/DD/YY)
01/31/2014
(Street)
WESTBROOK, ME04092
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/31/2014 M 13,000 A $ 25.45 390,271 ( 1 ) D
Common Stock 01/31/2014 M 7,000 A $ 41.935 397,271 D
Common Stock 01/31/2014 M 25,000 A $ 50 422,271 D
Common Stock 01/31/2014 S( 2 ) 12,589 D $ 112.4482 ( 3 ) 409,682 D
Common Stock 01/31/2014 S( 2 ) 9,900 D $ 113.3537 ( 4 ) 399,782 D
Common Stock 01/31/2014 S( 2 ) 16,600 D $ 114.1165 ( 5 ) 383,182 D
Common Stock 02/03/2014 M 15,072 A $ 25.45 398,254 D
Common Stock 02/03/2014 M 8,616 A $ 41.935 406,870 D
Common Stock 02/03/2014 M 25,000 A $ 50 431,870 D
Common Stock 02/03/2014 S( 2 ) 11,300 D $ 110.3855 ( 6 ) 420,570 D
Common Stock 02/03/2014 S( 2 ) 19,400 D $ 111.3895 ( 7 ) 401,170 D
Common Stock 02/03/2014 S( 2 ) 2,986 D $ 112.654 ( 8 ) 398,184 D
Common Stock 02/03/2014 S( 2 ) 8,519 D $ 113.2903 ( 9 ) 389,665 D
Common Stock 49,000 I By Ayers Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $ 25.45 01/31/2014 M 13,000 ( 10 ) 02/04/2014 Common Stock 13,000 $ 0 15,072 D
Non-Qualified Stock Option (right to buy) $ 41.935 01/31/2014 M 7,000 ( 11 ) 02/13/2014 Common Stock 7,000 $ 0 8,616 D
Non-Qualified Stock Option (right to buy) $ 50 01/31/2014 M 25,000 ( 12 ) 02/13/2014 Common Stock 25,000 $ 0 25,000 D
Non-Qualified Stock Option (right to buy) $ 25.45 02/03/2014 M 15,072 ( 10 ) 02/04/2014 Common Stock 15,072 $ 0 0 D
Non-Qualified Stock Options (right to buy) $ 41.935 02/03/2014 M 8,616 ( 11 ) 02/13/2014 Common Stock 8,616 $ 0 0 D
Non-Qualified Stock Options (right to buy) $ 50 02/03/2014 M 25,000 ( 12 ) 02/13/2014 Common Stock 25,000 $ 0 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
AYERS JONATHAN W
ONE IDEXX DRIVE
WESTBROOK, ME04092
X Chairman, President & CEO
Signatures
Jennifer L. Panciocco, Attorney-in Fact for Jonathan W. Ayers 02/04/2014
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Includes 60 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2013.
( 2 )The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/28/2013.
( 3 )The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $111.8450 to $112.8200, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3, 4, 5, 6, 7, 8 and 9 to this Form 4.
( 4 )The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $112.8500 to $113.8300, inclusive.
( 5 )The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $113.8500 to $114.3600, inclusive.
( 6 )The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $109.8600 to $110.8500, inclusive.
( 7 )The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $110.8600 to $111.8450 inclusive.
( 8 )The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $111.9136 to $112.9000, inclusive.
( 9 )The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $112.9200 to $113.6900, inclusive.
( 10 )Grant of options to buy shares of common stock becomes exercisable as to 22,000 shares on 02/05/2005, 02/05/2006, 02/05/2007 and 02/05/2008, and the remaining 18,072 shares on 02/05/2009.
( 11 )Grant of options to buy shares of common stock becomes exercisable as to 12,000 shares on 02/14/2008, 02/14/2009, 02/14/2010 and 02/14/2011, and the remaining 9,616 shares on 02/14/2012.
( 12 )Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.